Home
About
Overview
Sharing Data
ORCID
Help
History (15)
Allogeneic transplantation for recurrent or refractory non-Hodgkin's lymphoma with poor prognostic features after conditioning with thiotepa, busulfan, and cyclophosphamide: experience in 44 consecutive patients.
Comparison of single versus multiple spontaneous extra- and/or intracranial arterial dissection.
KRYPTOR-automated angiogenic factor assays and risk of preeclampsia-related adverse outcomes.
Primary acquired hypogammaglobulinemia and regional enteritis.
Repurposing Drugs for Cancer Radiotherapy: Early Successes and Emerging Opportunities.
See All 15 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Repurposing Drugs for Cancer Radiotherapy: Early Successes and Emerging Opportunities.
Repurposing Drugs for Cancer Radiotherapy: Early Successes and Emerging Opportunities. Cancer J. 2019 Mar/Apr; 25(2):106-115.
View in:
PubMed
subject areas
Chemoradiotherapy
Drug Repositioning
Humans
Neoplasms
authors with profiles
Stephen J. Kron
Ralph R. Weichselbaum